Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced the appointment of Mr. Li Xiaojun as an authorized representative on the Hong Kong Stock Exchange, effective June 16, 2025. Mr. Li, who is also the Chairman of the Board, brings significant expertise in corporate management and innovation, which is expected to strengthen the company’s compliance and strategic positioning in the market.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company based in the People’s Republic of China, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products, focusing on corporate management, financial and taxation management, and innovation.
YTD Price Performance: -0.55%
Average Trading Volume: 1,335,345
Technical Sentiment Signal: Hold
Current Market Cap: HK$45.1B
For detailed information about 0874 stock, go to TipRanks’ Stock Analysis page.